Showcases Stock ranks Forex

Eli Lilly and Company (LLY)
196.21  1.27 (0.65%) 05-14 16:03
Open: 194.75 Pre. Close: 194.75
High: 195.65 Low: 192.73
Volume: 1,774,755 Market Cap: 188,260M
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; and Sermonix Pharmaceuticals Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 196.544 - 197.483 197.483 - 198.335
Low: 190.414 - 191.523 191.523 - 192.529
Close: 194.385 - 196.206 196.206 - 197.858
Stock Technical Analysis
Target: Six months: 229.64
One year: 268.22
Support: Support1: 185.47
Support2: 178.58
Resistance: Resistance1: 196.61
Resistance2: 229.64
Pivot: 189.67
Moving Averages: MA(5): 194.77
MA(20): 189.60
MA(100): 190.86
MA(250): 167.33
MACD: MACD(12,26): 2.06
Signal(12,26,9): 0.99
%K %D: %K(14,3): 89.87
%D(3): 87.96
RSI: RSI(14): 63.06
52-Week: High: 218
Low: 129.21
Change(%): 24.2
Average Vol(K): 3-Month: 338485
10-Days: 254951
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

LLY has closed below upper band by 20.5%. Bollinger Bands are 1.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Wed, 12 May 2021
Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 13, 2021 - Nasdaq

Tue, 11 May 2021
Lilly and MiNA Therapeutics Announce saRNA Research Collaboration - PRNewswire

Sun, 09 May 2021
Should You Buy Eli Lilly and Company (NYSE:LLY) For Its Upcoming Dividend? - Yahoo Finance

Tue, 04 May 2021
How Eli Lilly and Company Cracked an Inclusive Approach in Health Communications - Adweek

Tue, 04 May 2021
Was The Smart Money Right About Eli Lilly and Company (LLY)? - Yahoo Finance

Mon, 03 May 2021
Lilly Declares Second-Quarter 2021 Dividend and Announces Additional Share Repurchase Authorization - PRNewswire

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 958.99
Shares Float (M) 856.60
% Held by Insiders 0.15
% Held by Institutions 83.75
Shares Short (K) 6380
Shares Short Prior Month (K) 6980
Stock Financials
EPS 6.680
Book Value (p.s.) 6.220
Profit Margin 23.91
Operating Margin 30.35
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 16.1
Gross Profit (p.s.) 19.875
Sales Per Share 26.580
EBITDA (p.s.) 9.510
Qtrly Earnings Growth -6.90
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio 29.37
PEG Ratio
Price to Book value 31.55
Price to Sales 7.38
Price to Cash Flow
Stock Dividends
Dividend 3.070
Dividend Yield 0.02
Dividend Growth 3.400

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator